Preclinical Antitumor Activity of Thiarabine in Human Leukemia and Lymphoma Xenograft Models

Author： Waud William R.   Gilbert Karen S.   Secrist John A.  

Publisher： Taylor & Francis Ltd

ISSN： 1525-7770

Source： Nucleosides, Nucleotides & Nucleic Acids, Vol.31, Iss.9, 2012-09, pp. : 647-660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical disposition and pharmacokinetics-pharmacodynamic modeling of biomarker response and tumour growth inhibition in xenograft mouse models of G-573, a MEK inhibitor

By Choo Edna F.   Belvin Marcia   Chan Jocelyn   Hoeflich Klaus   Orr Christine   Robarge Kirk   Yang Xiaoye   Zak Mark   Boggs Jason  

Xenobiotica, Vol. 40, Iss. 11, 2010-11 ,pp. : 751-762

Informa Healthcare

Access to resources Recommend Favorite

Fludarabine Induces Differential Expression of Proteins in Human Leukemia and Lymphoma Cells

By Henrich S.   Gez S.   Crossett B.   Mulligan S. P.   Christopherson R. I.  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 27, Iss. 6-7, 2008-06 ,pp. : 634-640

Taylor & Francis Ltd

Access to resources Recommend Favorite

A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia

By Mallikaratchy Prabodhika R.  

Nucleic Acids Research, Vol. 39, Iss. 6, 2011-03 ,pp. : 2458-2469

Oxford University Press

Access to resources Recommend Favorite

Antitumor activity of an adenovirus harboring human IL-24 in colon cancer

By Chang Shujian   Yang Jicheng   Chen Weichang   Xie Yufeng   Sheng Weihua  

Molecular Biology Reports, Vol. 38, Iss. 1, 2011-01 ,pp. : 395-401

Springer Publishing Company

Access to resources Recommend Favorite

Biochemical markers in preclinical models of osteoporosis

By Sørensen M. G.   Henriksen K.   Schaller S.   Karsdal M. A.  

Biomarkers, Vol. 12, Iss. 3, 2007-05 ,pp. : 266-286

Informa Healthcare

Access to resources Recommend Favorite